These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27500873)

  • 21. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of anxiety sensitivity on opioid use disorder treatment outcomes.
    Baxley C; Weinstock J; Lustman PJ; Garner AA
    Exp Clin Psychopharmacol; 2019 Feb; 27(1):64-77. PubMed ID: 30080059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Adding Memantine to Clonidine in Reducing Withdrawal Symptoms in Opioid-Dependent Patients: A Double-Blind Randomized Controlled Trial.
    Kheirabadi G; Najafian N; Khodadadi F
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):644-649. PubMed ID: 34559090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open-label randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department.
    Klein LR; Cole JB; Driver BE; Miner JR; Laes JR; Fagerstrom E; L Martel M
    Clin Toxicol (Phila); 2019 Aug; 57(8):697-702. PubMed ID: 30712404
    [No Abstract]   [Full Text] [Related]  

  • 27. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].
    Krupitsky EM; Rybakova KV; Skurat EP; Semenova NV; Neznanov NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):33-43. PubMed ID: 32105267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized effectiveness trial of methadone, TENS and methadone plus TENS in management of opiate withdrawal symptoms.
    Bakhshani NM; Lashkaripour K; Sadjadi SA
    J Pak Med Assoc; 2008 Dec; 58(12):667-71. PubMed ID: 19157318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial.
    Zarghami M; Masoum B; Shiran MR
    J Addict Dis; 2012; 31(2):112-7. PubMed ID: 22540433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification.
    Vernon MK; Reinders S; Mannix S; Gullo K; Gorodetzky CW; Clinch T
    Addict Behav; 2016 Sep; 60():109-16. PubMed ID: 27124502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings.
    Sinha R; Kimmerling A; Doebrick C; Kosten TR
    Psychopharmacology (Berl); 2007 Mar; 190(4):569-74. PubMed ID: 17136399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonidine detoxification: a fourteen-day protocol for rapid opiate withdrawal.
    Gold MS; Pottash AL; Sweeney DR; Kleber HD
    NIDA Res Monogr; 1979; 27():226-32. PubMed ID: 121338
    [No Abstract]   [Full Text] [Related]  

  • 36. Intentional intrathecal opioid detoxification in 3 patients: characterization of the intrathecal opioid withdrawal syndrome.
    Jackson TP; Lonergan DF; Todd RD; Martin PR
    Pain Pract; 2013 Apr; 13(4):297-309. PubMed ID: 22925591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581].
    Assadi SM; Radgoodarzi R; Ahmadi-Abhari SA
    BMC Psychiatry; 2003 Nov; 3():16. PubMed ID: 14624703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
    Ponizovsky AM; Grinshpoon A; Margolis A; Cohen R; Rosca P
    Addict Behav; 2006 Nov; 31(11):2002-13. PubMed ID: 16524668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.
    Wallen MC; Lorman WJ; Gosciniak JL
    J Addict Dis; 2006; 25(1):23-31. PubMed ID: 16597570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.